Literature DB >> 27988403

Asian American and Pacific Islander substance use treatment admission trends.

Ethan Sahker1, Chi W Yeung2, Yunkyoung L Garrison2, Soeun Park2, Stephan Arndt3.   

Abstract

BACKGROUND: A national analysis of Asian Americans and Pacific Islanders (AAPI) substance use treatment admissions has yet to be studied. We sought to explore admission trends for AAPI, demographic and treatment variable change, and individual state admission change over time.
METHODS: We used retrospective time-series logistic regression treating year as a predictor of yearly treatment admission trends, between-state test for heterogeneity of treatment effects among states' AAPI admissions, and percent-changes of AAPI demographic and treatment characteristics. Participants included AAPI (n=135,356) and comparison non-AAPI (n=8,938,982) treatment groups' first-time admissions (N=9,074,338) in United States treatment centers receiving public funding from 2000 to 2012.
RESULTS: AAPI demonstrated a greater increase in admissions than non-AAPI from 2000 to 2012 (p<0.0001; OR=1.02, 95% CI=1.019-1.022). Large percent increases were demonstrated in multiple demographic and treatment characteristic, most notably in prescription opioids as a problem substance, age of first use for the oldest and youngest groups, and homelessness. In addition, trends are provided for individual states to help prioritize resource need.
CONCLUSIONS: The present demographic and treatment characteristics revealed specific variables that may help to improve a culturally competent understanding of increasing risk factors among AAPI clients. The present findings may help to demonstrate which states may need to increase AAPI-specific resources and interventions.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Culturally competent treatment; Health disparity; Model minority; Prescription opioids

Mesh:

Year:  2016        PMID: 27988403     DOI: 10.1016/j.drugalcdep.2016.11.022

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  7 in total

1.  Racial/Ethnic Differences in Alcohol and Drug Use Outcomes Following Screening, Brief Intervention, and Referral to Treatment (SBIRT) in Federally Qualified Health Centers.

Authors:  Ethan Sahker; DeShauna Jones; Donna A Lancianese; George Pro; Stephan Arndt
Journal:  J Racial Ethn Health Disparities       Date:  2019-07-30

2.  Posttraumatic stress symptoms, shame, and substance use among Asian Americans.

Authors:  T Saraiya; K Z Smith; A N C Campbell; D Hien
Journal:  J Subst Abuse Treat       Date:  2018-10-10

3.  Racial/ethnic differences in prescription opioid misuse and heroin use among a national sample, 1999-2018.

Authors:  Megan S Schuler; Terry L Schell; Eunice C Wong
Journal:  Drug Alcohol Depend       Date:  2021-02-13       Impact factor: 4.492

4.  Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013: Results From the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; S Patricia Chou; Tulshi D Saha; Roger P Pickering; Bradley T Kerridge; W June Ruan; Boji Huang; Jeesun Jung; Haitao Zhang; Amy Fan; Deborah S Hasin
Journal:  JAMA Psychiatry       Date:  2017-09-01       Impact factor: 21.596

5.  Race Differences in Opioid Misuse and Adolescent Suicidality.

Authors:  Keith Tsz-Kit Chan; Shangyun Zhou; Christina Marsack-Topolewski
Journal:  Child Adolesc Social Work J       Date:  2020-11-05

Review 6.  Determinants and Prevention Strategies of Substance Abuse in Pacific Countries: A Systematic Review.

Authors:  Masoud Mohammadnezhad; Anjali Thomas; Russell Kabir
Journal:  Oman Med J       Date:  2020-09-30

7.  Use of a machine learning framework to predict substance use disorder treatment success.

Authors:  Laura Acion; Diana Kelmansky; Mark van der Laan; Ethan Sahker; DeShauna Jones; Stephan Arndt
Journal:  PLoS One       Date:  2017-04-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.